Received May 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | Y49BZ | — |
Administration to an patient under the age (3 YO); This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 3-year-old male patient who received DTPa-IPV (Kinrix) (batch number Y49BZ, expiry date 17-MAY-2026) for prophylaxis. On 10-APR-2025, the patient received Kinrix. On 10-APR-2025, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Administration to an patient under the age (3 YO)). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 02-MAY-2025 The reporter reported on 02-May-2025 a the nurse gave an 8 month old baby the Kinrix. The Vaccine Administration Facility is the same as Primary Reporter. The Healthcare professional reported that the patient was 8 month at the moment of the vaccination, but as we escalated this to 2nd line, HCP mentioned to my coworker that the real age of the patient was 3 years old which led to the inappropriate age at vaccine administration.